Similarly, a cohort study, also conducted in a Chinese population, initially found a lower diabetes risk in participants with HBsAg-negative/anti-HBs-positive/anti-HBc-negative status (implying immunity due to hepatitis B vaccination) than in those with HBsAg-negative/anti-HBs-negative/anti-HBc-negative status (indicating susceptibility to HBV) in an unadjusted model (HR: 0.89, 95% CI: 0.84–0.95, p = 0.0002). Here, KRT88P is linked to hepatitis B virus infection.